Private Market View

Redmile Group

PE / buyout · San Francisco, California

AUM
$4.8B
Portfolio companies
20
Recorded deals
2
Last investment

Key facts

  • Redmile Group is a private equity firm based in San Francisco, California with 20 tracked portfolio companies.
  • Notable positions include Lantern (Managed Care), Abcuro, Candid Therapeutics, Strand Therapeutics, Bambusa Therapeutics.
  • The team roster lists 14 people.
  • Redmile Group reports $3.2B in regulatory assets under management across 18 private funds, per its SEC Form ADV (2026-03).

About Redmile Group

Founded in 2007, Redmile Group is a private equity firm based in San Francisco, California. The firm seeks to invest in healthcare companies.

Registered with the SEC

Form ADV · 2026-03 · CRD 143606
Regulatory AUM
$3.2B
Private fund assets
$5.4B
Private funds
18 · 7 venture, 3 private equity, 8 hedge
Staff
30
Registered office
SAN FRANCISCO, CA
SEC status
Approved

Reports custody of client assets.

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as REDMILE GROUP, LLC).

Free account
See the whole book
  • ·The book's top 25 — of 20 recorded positions
  • ·Watchlist + alerts for Redmile Group's activity
Create free account
No card required

Portfolio, priced

20 companies · by our current valuations
CompanyValuationRole
Lantern (Managed Care)$1.0B
Abcuro$700.0M
Candid Therapeutics$657.0M
Strand Therapeutics$571.0M
Bambusa Therapeutics$555.0M
Electra Therapeutics$479.0M
AgomAb$415.6M
Clear Labs$413.0M
Attovia Therapeutics$370.0M
Neuron23$271.5M
Ambrosia Biosciences$203.0M
Impulse Dynamics$127.0M
Healthmine$54.0M
CorVent Medical$40.5M
OncoResponse$36.0M
+ 5 more companies · a free account shows the top of the book
Team
14 people on record — 12 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked

What companies does Redmile Group invest in?
Redmile Group has 20 recorded portfolio companies, including Lantern (Managed Care), Abcuro, Candid Therapeutics, Strand Therapeutics.
What is Redmile Group's AUM?
Redmile Group manages approximately $4.8B in assets.